Pilot Launch You have early access to the Barinhall Compliance Intelligence Portal. Coverage and features are expanding weekly. Share feedback →
← Back to Feed
View source document ↗
T4 SEC Medium Confidence Proposed Rule

SEC Proposes Amendments to Exchange Act Rule 15c2-11

Regulatory clarification to limit Rule 15c2-11 scope to equity securities only

MINIMAL
Impact Level
Top: compliance (2)

Classification

Regulatory Program
Exchange Act Rule 15c2-11
Doc Type
Proposed Rule
Effective Date
Days to Action
Comment Deadline
Published

Urgency Basis

Proposed rule with 60-day comment period, not yet finalized

Operational Context

Flags
Legal Review Required
Affected Functions
Capital Markets Trading Compliance
Institution Applicability
Broker-Dealers Market Makers Otc Trading Firms

Impact by Category

Compliance
2
Operational
1
Data Governance
0
Model Risk
0
Reporting & Disclosure
1
Capital & Liquidity
0
Consumer Protection
1
Third-Party Risk
1

Key Requirements

- Review quotation publication practices for OTC equity securities - Ensure compliance procedures align with clarified equity-only scope - Update internal policies to reflect amended rule definition - Monitor Federal Register publication for final comment deadline

Scoring Rationale

This is a clarifying amendment that narrows the scope of an existing rule to equity securities only, affirming what was already understood in practice. The impact is minimal across all categories as it represents regulatory housekeeping rather than substantive new requirements.

Scored: 2026-06-05T18:02:58.196Z Model: claude-sonnet-4-20250514 Confidence: Medium Aggregate Score: 1.0
AI Analysis Disclosure — This record, including its scores, impact assessments, and Advisory Assessment (impact, risk, and recommended actions), was generated by an AI model and may contain errors or omissions. The Advisory Assessment is a starting point for analysis, not a substitute for professional judgment. Effective dates, applicability determinations, impact assessments, and any recommended actions should be independently verified against primary regulatory source documents and reviewed by qualified compliance or legal personnel before taking compliance action. This output does not constitute legal or compliance advice.